Paul Gunn

Founder at Soricimed Biopharma, Inc.

Technology Services

Health Technology

Profile

Paul Gunn founded Soricimed Biopharma, Inc. in 2005, where he is working as President from 2019.
Mr. Gunn also formerly worked at Whitehill Technologies, Inc., as Vice President-Finance & Administration.

Paul Gunn active positions

Companies	Position	Start
Soricimed Biopharma, Inc. Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada.	Founder	2004-12-31

All active positions of Paul Gunn

Former positions of Paul Gunn

Companies	Position	End
Whitehill Technologies, Inc. Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada.	Director of Finance/CFO	-

See the detail of Paul Gunn's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Gunn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Whitehill Technologies, Inc. Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada.	Technology Services
Soricimed Biopharma, Inc. Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada.	Health Technology

See company connections